Standard BioTools
LAB
LAB
125 hedge funds and large institutions have $296M invested in Standard BioTools in 2019 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 46 increasing their positions, 41 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
32% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 31
66% less capital invested
Capital invested by funds: $864M → $296M (-$569M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
125
Holding in Top 10
–
Calls
$1.56M
Puts
$258K
Top Buyers
| 1 | +$12.6M | |
| 2 | +$8.02M | |
| 3 | +$3.04M | |
| 4 |
D.E. Shaw & Co
New York
|
+$2.5M |
| 5 |
ECM
Endurant Capital Management
San Mateo,
California
|
+$1.83M |
Top Sellers
| 1 | -$22.4M | |
| 2 | -$13.3M | |
| 3 | -$7.54M | |
| 4 |
Morgan Stanley
New York
|
-$6.84M |
| 5 |
Russell Investments Group
London,
United Kingdom
|
-$6.62M |